Myoungil Cha - 17 Jun 2024 Form 4 Insider Report for TANDEM DIABETES CARE INC (TNDM)

Role
Director
Signature
/s/ Rachel Malina, Attorney-in-Fact for Myoungil Cha
Issuer symbol
TNDM
Transactions as of
17 Jun 2024
Net transactions value
+$79,282
Form type
4
Filing time
20 Jun 2024, 16:42:17 UTC
Previous filing
24 May 2024
Next filing
23 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNDM Common Stock Options Exercise $79,282 +1,749 +30% $45.33 7,563 17 Jun 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNDM Restricted Stock Unit Options Exercise $0 -1,749 -50% $0.000000 1,749 17 Jun 2024 Common Stock 1,749 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Awarded on June 15, 2022 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).
F2 Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.
F3 The total number of shares subject to the RSU will vest over a period of three years in equal annual installments on the anniversary of the grant, subject to the terms of the 2013 Plan.